Uniunea Europeană - română - EMA (European Medicines Agency)

vertex pharmaceuticals (ireland) limited - tezacaftor, ivacaftor - fibroză chistică - alte produse ale sistemului respirator - symkevi is indicated in a combination regimen with ivacaftor tablets for the treatment of patients with cystic fibrosis (cf) aged 6 years and older who are homozygous for the f508del mutation or who are heterozygous for the f508del mutation and have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (cftr) gene: p67l, r117c, l206w, r352q, a455e, d579g, 711+3a→g, s945l, s977f, r1070w, d1152h, 2789+5g→a, 3272 26a→g, and 3849+10kbc→t.

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

almac pharma services (ireland) limited - irlanda - tezacaftorum+ivacaftorum - compr. film. - 100mg/150mg - alte med. pentru tratamentul ap. respirator alte med. pt. aparatul respirator

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

almac pharma services (ireland) limited - irlanda - tezacaftorum+ivacaftorum - compr. film. - 50mg/75mg - alte med. pentru tratamentul ap. respirator alte med. pt. aparatul respirator